CO2 pneumoperitoneum increases survival in mice with polymicrobial peritonitis

Area of Science:

• Surgical Innovation
• Immunology
• Critical Care Medicine

Background:

• Laparoscopic surgery frequently employs carbon dioxide (CO2) pneumoperitoneum.
• CO2 is known to suppress inflammatory responses, yet an active immune system is crucial for combating abdominal bacterial contamination.
• The impact of CO2 pneumoperitoneum on immune function during polymicrobial peritonitis requires investigation.

Purpose of the Study:

• To investigate the early and late effects of CO2 pneumoperitoneum on the ability of mice to overcome polymicrobial peritonitis.
• To compare the effects of CO2 pneumoperitoneum with helium pneumoperitoneum and simple laparotomy on survival rates.

Main Methods:

• Male C57/B6 mice underwent CO2 or helium pneumoperitoneum, or laparotomy.
• Polymicrobial peritonitis was induced either 1 hour after pneumoperitoneum/laparotomy or 4 hours prior to it.
• Survival rates were monitored for 7 days, distinguishing between early (6-48 hours) and late (>48 hours) outcomes.

Main Results:

• CO2 pneumoperitoneum significantly reduced early mortality (6-48 hours) in mice subjected to subsequent polymicrobial peritonitis compared to laparotomy (p < 0.05).
• Helium pneumoperitoneum did not demonstrate any beneficial effect on survival.
• CO2 pneumoperitoneum applied during established polymicrobial peritonitis also significantly reduced overall mortality (p < 0.05).

Conclusions:

• CO2 pneumoperitoneum, unlike helium, positively modulates immune responses, significantly improving survival during abdominal sepsis in a murine model.
• CO2 pneumoperitoneum may offer therapeutic benefits in clinical scenarios involving bacterial contamination of the abdominal cavity.
• Further research into the immunomodulatory mechanisms of CO2 pneumoperitoneum is warranted.